Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Other Non-Current Liabilities: 2015

Historic Other Non-Current Liabilities for Viking Therapeutics (VKTX) over the last 1 years, with Dec 2015 value amounting to $183,611.

  • Viking Therapeutics' Other Non-Current Liabilities fell 76.78% to $47,113 in Q1 2017 from the same period last year, while for Mar 2017 it was $47,113, marking a year-over-year decrease of 76.78%. This contributed to the annual value of $183,611 for FY2015, which is N/A change from last year.
  • According to the latest figures from FY2015, Viking Therapeutics' Other Non-Current Liabilities is $183,611.
  • In the past 5 years, Viking Therapeutics' Other Non-Current Liabilities ranged from a high of $183,611 in FY2015 and a low of $183,611 during FY2015.
  • For the 1-year period, Viking Therapeutics' Other Non-Current Liabilities averaged around $183,611, with its median value being $183,611 (2015).